Project Grant HT94252510400
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$296K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10021, USA
Similar Awards
The U.S. Defense Health Agency awarded a $300,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the New York Society For Relief Of Ruptured & Crippled Maintaining The Hospital For Special Surgery. The grant supports advanced biomedical research aimed at investigating novel mechanisms that prevent systemic lupus erythematosus (SLE). The award period is from Sep 1, 2025 to Aug 31, 2027. The Hospital for Special Surgery, a prominent non-profit...
The Department of the Army Medical Command awarded a $1,499,782 Project Grant to the New York Society For Relief Of Ruptured & Crippled Maintaining The Hospital For Special Surgery under the Military Medical Research and Development program. This three-year award beginning July 1, 2022 will support research into photosensitivity and lymph node immune responses in lupus. The Military Medical Research and Development program aims to advance biomedical research that improves health care for...
The Department of Defense's Military Medical Research and Development (CFDA 12.420) program awarded a $300,000 Project Grant to Duke University to investigate the "Complement-Activating Properties of Anti-Sm/RNP Antibodies in SLE". This 2-year research effort, starting on September 1, 2024 and ending on August 31, 2026, aims to advance biomedical research that can transform healthcare for military service members, veterans, and the broader public. The Military Medical Research and...
This $997,821 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research into the pathogenic role of neutrophil subpopulations in lupus nephritis. The primary awardee is Trustees of Dartmouth College, with sub-awards to The Johns Hopkins University and Dartmouth-Hitchcock Clinic. This multi-institutional effort will investigate the underlying mechanisms of neutrophil-driven pathology in lupus nephritis, with...
The federal Project Grant award, totaling $999,972.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Feinstein Institutes For Medical Research. The grant supports a study focused on "Studying Urine Macrophages in Lupus Nephritis to Shed Light on Kidney Disease Processes." The research aims to advance the understanding of lupus nephritis, a serious kidney condition, by examining immune cells in urine samples....
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
The University of Houston System was awarded a $999,465 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2025, supports the development of selective spleen-targeted nanoparticles as drug delivery vehicles for the treatment of lupus. This research aims to transform healthcare for military service members and the broader public by advancing innovative biomedical solutions. The program...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $299,937.00 to The Feinstein Institutes For Medical Research to conduct research on visualizing neural synaptic density in systemic lupus erythematosus (SLE) to better understand mechanisms of brain dysfunction. The award period runs from July 15, 2024 to July 14, 2026. The Feinstein Institutes, a non-profit research organization, will utilize this...
The University of Houston received a $299,787 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project from May 1, 2023 to April 30, 2025 to evaluate the diagnostic utility of antibodies to histone post-translational modifications in pediatric lupus patients. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with...
The federal Project Grant award, identified as HT94252510088, is provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, totaling $1,618,114.00, supports research conducted by The General Hospital Corporation (doing business as Massachusetts General Hospital) to define the role of anti-nephrin antibodies in the recurrence of focal segmental glomerulosclerosis post transplantation. This 3-year research project, with a period of...